JPY 2560.0
(-0.58%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 60.1 Billion JPY | -13.35% |
2022 | 69.36 Billion JPY | 6.14% |
2021 | 65.34 Billion JPY | -4.76% |
2020 | 68.61 Billion JPY | 22.77% |
2019 | 55.88 Billion JPY | 71.31% |
2018 | 32.62 Billion JPY | 497.6% |
2017 | 5.45 Billion JPY | -28.27% |
2016 | 7.61 Billion JPY | -22.45% |
2015 | 9.81 Billion JPY | -62.67% |
2014 | 26.28 Billion JPY | 20.57% |
2013 | 21.8 Billion JPY | -9.15% |
2012 | 23.99 Billion JPY | -14.52% |
2011 | 28.07 Billion JPY | 1088.53% |
2010 | 2.36 Billion JPY | 179.86% |
2009 | 844 Million JPY | 41.61% |
2008 | 596 Million JPY | -66.83% |
2007 | 1.79 Billion JPY | -47.87% |
2006 | 3.44 Billion JPY | -26.03% |
2005 | 4.66 Billion JPY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 60.1 Billion JPY | 0.0% |
2023 Q3 | 60.1 Billion JPY | -6.09% |
2023 Q1 | 62.8 Billion JPY | -9.46% |
2023 Q2 | 64 Billion JPY | 1.91% |
2023 FY | 60.1 Billion JPY | -13.35% |
2023 Q4 | 60.1 Billion JPY | 0.0% |
2022 Q2 | 50 Billion JPY | 0.0% |
2022 Q4 | 69.36 Billion JPY | 38.72% |
2022 Q3 | 50 Billion JPY | 0.0% |
2022 FY | 69.36 Billion JPY | 6.14% |
2022 Q1 | 50 Billion JPY | -23.49% |
2021 Q4 | 65.34 Billion JPY | 21.69% |
2021 Q1 | 55.51 Billion JPY | -19.1% |
2021 Q3 | 53.7 Billion JPY | -3.26% |
2021 Q2 | 55.51 Billion JPY | 0.0% |
2021 FY | 65.34 Billion JPY | -4.76% |
2020 Q2 | 49.13 Billion JPY | -0.55% |
2020 Q1 | 49.4 Billion JPY | -11.6% |
2020 Q3 | 47.32 Billion JPY | -3.69% |
2020 Q4 | 68.61 Billion JPY | 44.99% |
2020 FY | 68.61 Billion JPY | 22.77% |
2019 FY | 55.88 Billion JPY | 71.31% |
2019 Q4 | 55.88 Billion JPY | 20.21% |
2019 Q3 | 46.49 Billion JPY | 64.31% |
2019 Q2 | 28.29 Billion JPY | -0.94% |
2019 Q1 | 28.56 Billion JPY | -12.45% |
2018 Q1 | 18.67 Billion JPY | 242.13% |
2018 Q4 | 32.62 Billion JPY | 2.03% |
2018 FY | 32.62 Billion JPY | 497.6% |
2018 Q3 | 31.97 Billion JPY | 69.96% |
2018 Q2 | 18.81 Billion JPY | 0.73% |
2017 Q3 | 3.29 Billion JPY | 0.0% |
2017 FY | 5.45 Billion JPY | -28.27% |
2017 Q4 | 5.45 Billion JPY | 65.47% |
2017 Q2 | 3.29 Billion JPY | -23.26% |
2017 Q1 | 4.29 Billion JPY | -43.51% |
2016 Q2 | 5.29 Billion JPY | -15.88% |
2016 Q1 | 6.29 Billion JPY | -35.81% |
2016 Q3 | 5.29 Billion JPY | 0.0% |
2016 FY | 7.61 Billion JPY | -22.45% |
2016 Q4 | 7.61 Billion JPY | 43.61% |
2015 Q4 | 9.81 Billion JPY | -43.28% |
2015 FY | 9.81 Billion JPY | -62.67% |
2015 Q3 | 17.3 Billion JPY | -10.36% |
2015 Q2 | 19.3 Billion JPY | -4.93% |
2015 Q1 | 20.3 Billion JPY | -22.77% |
2014 Q3 | 14 Billion JPY | -12.5% |
2014 Q2 | 16 Billion JPY | 0.0% |
2014 FY | 26.28 Billion JPY | 20.57% |
2014 Q4 | 26.28 Billion JPY | 87.75% |
2014 Q1 | 16 Billion JPY | -26.61% |
2013 Q3 | 18.25 Billion JPY | -9.88% |
2013 Q2 | 20.25 Billion JPY | -0.18% |
2013 Q1 | 20.28 Billion JPY | -15.46% |
2013 FY | 21.8 Billion JPY | -9.15% |
2013 Q4 | 21.8 Billion JPY | 19.45% |
2012 Q4 | 23.99 Billion JPY | 8.01% |
2012 Q1 | 24.39 Billion JPY | -13.12% |
2012 Q3 | 22.21 Billion JPY | -8.77% |
2012 Q2 | 24.35 Billion JPY | -0.16% |
2012 FY | 23.99 Billion JPY | -14.52% |
2011 Q3 | 16.53 Billion JPY | 2451.54% |
2011 FY | 28.07 Billion JPY | 1088.53% |
2011 Q2 | 648 Million JPY | -12.2% |
2011 Q1 | 738 Million JPY | -68.76% |
2011 Q4 | 28.07 Billion JPY | 69.79% |
2010 FY | 2.36 Billion JPY | 179.86% |
2010 Q3 | 812 Million JPY | -11.74% |
2010 Q4 | 2.36 Billion JPY | 190.89% |
2010 Q2 | 920 Million JPY | -6.79% |
2010 Q1 | 987 Million JPY | 16.94% |
2009 Q3 | 128 Million JPY | -16.34% |
2009 FY | 844 Million JPY | 41.61% |
2009 Q4 | 844 Million JPY | 559.38% |
2009 Q2 | 153 Million JPY | 0.0% |
2008 Q3 | 797 Million JPY | 0.0% |
2008 FY | 596 Million JPY | -66.83% |
2008 Q4 | 596 Million JPY | -25.22% |
2007 FY | 1.79 Billion JPY | -47.87% |
2006 FY | 3.44 Billion JPY | -26.03% |
2005 FY | 4.66 Billion JPY | 0.0% |
2004 Q4 | 10.17 Billion JPY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 18.14 Billion JPY | -231.168% |
DNA Chip Research Inc. | - JPY | -Infinity% |
Cosmo Bio Company,Limited | - JPY | -Infinity% |
FALCO HOLDINGS Co., Ltd. | 148 Million JPY | -40508.108% |
BML, Inc. | 3.73 Billion JPY | -1510.397% |
Human Metabolome Technologies, Inc. | 11.34 Million JPY | -529695.487% |
Precision System Science Co., Ltd. | 289.67 Million JPY | -20647.533% |